Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial. Lancet Gastroenterol Hepatol 2020; 5: 548-560.

Published: 17th November 2020

Authors: Li J, Xing J, Yang Y, Liu J, Wang W, Xia Y et al.

Conclusion

Some 156 patients were included. After median follow-up of 55.9 months, relapse-free survival was 43.4 per cent after active treatment versus 21.7 per cent in controls (hazard ratio 0.49, 95 per cent confidence interval 0.34 to 0.72, P=0.0031).

Pubmed Link

You may also be interested in

Scientific Surgery

Antiviral therapy reduces hepatocellular carcinoma recurrence in patients with low HBV-DNA levels. A randomized controlled trial. Ann Surg 2018: 268: 943-954.

Authors: Huang G, Li P-P, Lau WY, Pan Z-Y, Zhao L-H, Wang Z-G et al.

Scientific Surgery

Radiofrequency ablation using a 10‐mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: A prospective randomized trial. J Surg Oncol 2017; 115: 971-979.

Scientific Surgery

Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst 2017; 109. doi: 10.1093/jnci/djx015.

Authors: Ruers T, Van Coevorden F, Punt CJA, Pierie J-PEN, Borel-Rinkes I, Ledermann JA et al.

Scientific Surgery

Fibrin sealant patch (TachoSil) vs oxidized regenerated cellulose patch (Surgicel Original) for the secondary treatment of local bleeding in patients undergoing hepatic resection: a randomized controlled trial. J Am Coll Surg 2012; 222: 261-268.

Authors: Genyk Y, Kato T, Pomposelli JJ, Wright Jr JK, Sher LS, Tetens V et al.

Scientific Surgery

Fibrin sealant with polyglycolic acid felt vs fibrinogen-based collagen fleece at the liver cut surface for prevention of postoperative bile leakage and hemorrhage: a prospective, randomized, controlled study. J Am Coll Surg 2016; 222: 59-64.

Authors: Kobayashi S, Takeda Y, Nakahira S, Tsujie M, Shimizu J, Miyamoto A et al.

Scientific Surgery

Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial. Ann Surg 2015; 261: 56-66.

Authors: Huang G, Lau WY, Wang Z-G, Pan Z-Y, Yuan S-X, Feng S et al. et al.

Scientific Surgery

Adjuvant radiotherapy in centrally located hepatocellular carcinomas after hepatectomy with narrow margin (<1cm): a prospective randomized study. J Am Coll Surg 2014; 218: 381-392.

Authors: Yu W, Wang W, Rong W, Wang L, Xu Q, Wu F et al. et al.

Scientific Surgery

Adjuvant hepatic intra-arterial iodine 131- lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trial. World J Surg 2013; 37: 1356-1361.

Authors: Chung AY, Ooi LL, Machin D, Tan SB, Goh BK, Wong JS et al. et al.

Scientific Surgery

Radiofrequency ablation with or without transcatheter chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 2013; 31: 426-432.

Authors: Peng Z-W, Zhang Y-J, Chen M-S, Xu L, Lian H-L, Lin X-J et al. et al.

Scientific Surgery

Effects of pentoxifylline on liver regeneration: a double blinded, randomized clinical trial in 101 patients undergoing major liver resection. Ann Surg 2010; 252: 813-822.

Authors: Petrowsky H, Breitenstein S, Slankamenac K, Vetter D, Lechmann K, Heinrich S et al. et al.

Scientific Surgery

A prospective randomized controlled trial of preoperative transarterial chemoembolisation for resectable large hepatocellular carcinoma Ann Surg 2009; 249: 195-202

Authors: Zhou W-P, Lai ECH, Li A-J, Fu S-Y, Zhou J-Ppan Z-y et al

Scientific Surgery

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for respectable liver metastases from colorectal cancer (EORTC Intergroup Trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-1016.

Authors: Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al.